0001701259-20-000002.txt : 20200824 0001701259-20-000002.hdr.sgml : 20200824 20200824100242 ACCESSION NUMBER: 0001701259-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20200824 DATE AS OF CHANGE: 20200824 EFFECTIVENESS DATE: 20200824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Phage Therapeutics, Inc. CENTRAL INDEX KEY: 0001701259 IRS NUMBER: 814208730 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-373895 FILM NUMBER: 201125084 BUSINESS ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 125 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 2408992532 MAIL ADDRESS: STREET 1: 22 FIRSTFIELD ROAD STREET 2: SUITE 125 CITY: GAITHERSBURG STATE: MD ZIP: 20878 D 1 primary_doc.xml X0708 D LIVE 0001701259 Adaptive Phage Therapeutics, Inc. 22 FIRSTFIELD ROAD SUITE 125 GAITHERSBURG MD MARYLAND 20878 2408992532 DELAWARE None None Corporation true 2017 Gregory Louis Merril 22 Firstfield Road Suite125 Gaithersburg MD MARYLAND 20878 Executive Officer Director Carl Merril 22 Firstfield Road Suite125 Gaithersburg MD MARYLAND 20878 Executive Officer Director William Mutryn 22 Firstfield Road Suite125 Gaithersburg MD MARYLAND 20878 Director Pharmaceuticals Decline to Disclose 06c false 2020-06-05 false true false 0 7000000 3350000 3650000 ` false 18 0 0 0 false Adaptive Phage Therapeutics, Inc. /s/ Gregory Louis Merril Gregory Louis Merril CEO 2020-08-19